Hu YX - Search Results

1

Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Okai T, Sawabu N. Hu YX, et al. Clin Cancer Res. 1997 Sep;3(9):1473-7. Clin Cancer Res. 1997. PMID: 9815833

2

Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.

Ohtsubo K, Watanabe H, Yamaguchi Y, Hu YX, Motoo Y, Okai T, Sawabu N. Ohtsubo K, et al. Among authors: hu yx. J Gastroenterol. 2003;38(7):663-71. doi: 10.1007/s00535-003-1119-6. J Gastroenterol. 2003. PMID: 12898359 Free article.

3

Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma.

Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Motoo Y, Okai T, Sawabu N. Hu YX, et al. Clin Cancer Res. 1998 May;4(5):1147-52. Clin Cancer Res. 1998. PMID: 9607571

4

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.

Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Motoo Y, Okai T, Sawabu N. Hu YX, et al. Br J Cancer. 1999 Jun;80(7):1075-9. doi: 10.1038/sj.bjc.6690466. Br J Cancer. 1999. PMID: 10362119 Free PMC article.

5

K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.

Watanabe H, Ha A, Hu YX, Ohtsubo K, Yamaguchi Y, Motoo Y, Okai T, Toya D, Tanaka N, Sawabu N. Watanabe H, et al. Among authors: hu yx. Cancer. 1999 Oct 15;86(8):1441-8. Cancer. 1999. PMID: 10526271

6

Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.

Watanabe H, Yamaguchi Y, Ha A, Hu YX, Motoo Y, Okai T, Yoshimura T, Sawabu N. Watanabe H, et al. Among authors: hu yx. Pancreas. 1998 Nov;17(4):341-7. doi: 10.1097/00006676-199811000-00004. Pancreas. 1998. PMID: 9821175

7

An immunohistochemical analysis of p27 expression in human pancreatic carcinomas.

Hu YX, Watanabe H, Li P, Wang Y, Ohtsubo K, Yamaguchi Y, Sawabu N. Hu YX, et al. Pancreas. 2000 Oct;21(3):226-30. doi: 10.1097/00006676-200010000-00002. Pancreas. 2000. PMID: 11039465

8

Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells.

Athanassiou M, Hu Y, Jing L, Houle B, Zarbl H, Mikheev AM. Athanassiou M, et al. Cell Growth Differ. 1999 Nov;10(11):729-37. Cell Growth Differ. 1999. PMID: 10593649

9

Prognostic significance of differentially expressed miRNAs in esophageal cancer.

Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Hu Y, et al. Int J Cancer. 2011 Jan 1;128(1):132-43. doi: 10.1002/ijc.25330. Int J Cancer. 2011. PMID: 20309880 Free PMC article.

10

p53 inactivating mutations in Chinese nasopharyngeal carcinomas.

Lung ML, Hu Y, Cheng Y, Li MF, Tang CM, O SK, Iggo RD. Lung ML, et al. Cancer Lett. 1998 Nov 13;133(1):89-94. doi: 10.1016/s0304-3835(98)00209-2. Cancer Lett. 1998. PMID: 9929165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters